SFX by Ex Libris Inc.

Title:	Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
Source:	Nature [0028-0836] Breitbach, C J yr:2011

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Thorne, Steve H. "Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer." Nature reviews. Cancer 9.1 (2009): 64-71.
description	2.	Kay, M. "Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics." Nature medicine 7.1 (2001): 33-40.
description	3.	Gaiano, N. "A method for rapid gain-of-function studies in the mouse embryonic nervous system." Nature neuroscience 2.9 (1999): 812-9.
description	4.	Strati, K. "Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model." Proceedings of the National Academy of Sciences of the United States of America 103.38: 14152-7.
description	5.	Liu, Ta-Chiang C. "Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress." Nature clinical practice. Oncology 4.2 (2007): 101-17.
description	6.	Kim, J H H. "Systemic armed oncolytic and immunologic therapy for cancer with JX-594, a targeted poxvirus expressing GM-CSF." Molecular therapy 14.3 (2006): 361-370.
description	7.	Kirn, David H. H. "Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer.(OPINION)." Nature reviews. Cancer 9.1 (2009): 64-.
description	8.	Liu, T. "Gene therapy progress and prospects cancer : oncolytic viruses." Gene therapy 15.162822182 (2008): 877-884.
description	9.	Wu, T. "Immune barriers to successful gene therapy." Trends in molecular medicine 15.1 (2009): 32-39.
description	10.	Thomas, Clare E E. "Progress and problems with the use of viral vectors for gene therapy." Nature reviews. Genetics 4.5 (2003): 346-58.
description	11.	Robbins, S C D. "Viral vectors for gene therapy." Pharmacology & therapeutics 80.1 (1998): 35-47.
description	12.	Dias, N. "Antisense oligonucleotides: Basic concepts and mechanisms." Molecular cancer therapeutics 1.5 (2002): 347-355.
description	13.	Niidome, T. "Gene therapy progress and prospects: nonviral vectors." Gene therapy 10.24 (2003): 1647-52.
description	14.	Waehler, R. "Engineering targeted viral vectors for gene therapy." Nature reviews. Genetics 8.8 (2007): 573-87.
description	15.	HARKMARK, W. "Cell migrations from the rhombic lip to the inferior olive, the nucleus raphe and the pons; a morphological and experimental investigation on chick embryos." Journal of comparative neurology 100.1 (1954): 115-209.
description	16.	Bauer, K. "Molecular rearrangements in papillary thyroid carcinomas." Clinica chimica acta 411.5-6 (2010): 301-8.
description	17.	Petereit, T. "Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer." Cancer research 63.23 (2003): 8173-80.
description	18.	Grimm, C.. "The low abundance of U7 snRNA is partly determined by its Sm binding site." The EMBO journal 12.3 (1993): 1229-1238.
description	19.	Thomas, S J J. "Human papillomavirus and head and neck cancer: a systematic review and meta-analysis." Clinical otolaryngology 31.4 (2006): 259-66.
description	20.	Khan, I. "Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas." European journal of cancer 43.2 (2006): 415-32.